Analgesics in Australia

October 2021
USD 1,195
Request More Information


Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).


Understand the latest market trends and future growth opportunities for the Analgesics industry in Australia with research from Euromonitor International's team of in-country analysts – experts by industry and geographic specialisation.

Key trends are clearly and succinctly summarised alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight and confident growth projections.

If you're in the Analgesics industry in Australia, our research will help you to make informed, intelligent decisions; to recognise and profit from opportunity, or to offer resilience amidst market uncertainty.

The Analgesics in Australia report includes:

  • Analysis of key supply-side and demand trends
  • Detailed segmentation of international and local products
  • Historic volume and value sizes, company and brand market shares
  • Five year forecasts of market trends and market growth
  • Robust and transparent research methodology, conducted in-country

This report answers:

  • What is the market size of Analgesics in Australia?
  • Which are the leading brands in Analgesics in Australia?
  • How are products distributed in Analgesics in Australia?
  • How has the regulatory and operating environment for Analgesics changed in Australia?
  • How are considerations such as stress, self-medication and shifting consumer lifestyles shaping demand for Analgesics
  • How significant are wider health concerns and consumer awareness in determining sales?
  • Where is future growth expected to be most dynamic?

Analgesics in Australia - Category analysis



Strong demand for analgesics during pandemic continues to drive value sales in 2021
GSK Consumer Healthcare retains overall leadership of analgesics
Reckitt Benckiser remains strongest competitor to GSK Consumer Healthcare in 2021


Increase in elderly population suffering from chronic illnesses to support growth of analgesics over the forecast period
Solid demand for trusted analgesics in terms of efficacy
New entry intends to disrupt the competitive landscape


Table 1 Sales of Analgesics by Category: Value 2016-2021 Table 2 Sales of Analgesics by Category: % Value Growth 2016-2021 Table 3 NBO Company Shares of Analgesics: % Value 2017-2021 Table 4 LBN Brand Shares of Analgesics: % Value 2018-2021 Table 5 Forecast Sales of Analgesics by Category: Value 2021-2026 Table 6 Forecast Sales of Analgesics by Category: % Value Growth 2021-2026

Consumer Health in Australia - Industry Overview


Consumer health in 2021: The big picture
2021 key trends
Competitive landscape
Retailing developments
What next for consumer health?


Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2016-2021 Table 8 Life Expectancy at Birth 2016-2021


Table 9 Sales of Consumer Health by Category: Value 2016-2021 Table 10 Sales of Consumer Health by Category: % Value Growth 2016-2021 Table 11 NBO Company Shares of Consumer Health: % Value 2017-2021 Table 12 LBN Brand Shares of Consumer Health: % Value 2018-2021 Table 13 Penetration of Private Label in Consumer Health by Category: % Value 2016-2021 Table 14 Distribution of Consumer Health by Format: % Value 2016-2021 Table 15 Distribution of Consumer Health by Format and Category: % Value 2021 Table 16 Forecast Sales of Consumer Health by Category: Value 2021-2026 Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2021-2026


OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Summary 1 OTC: Switches 2020-2021




Summary 2 Research Sources
The following categories and subcategories are included:


      • Adult Acetaminophen
      • Adult Aspirin
      • Adult Combination Products - Analgesics
      • Adult Diclofenac
      • Adult Dipyrone
      • Adult Ibuprofen
      • Adult Ketoprofen
      • Adult Naproxen
      • Adult OTC Triptans
      • Paediatric Acetaminophen
      • Paediatric Aspirin
      • Paediatric Combination Products - Analgesics
      • Paediatric Dipyrone
      • Paediatric Ibuprofen
      • Paediatric Naproxen
      • Acetaminophen
      • Aspirin
      • Combination Products - Analgesics
      • Diclofenac
      • Dipyrone
      • Ibuprofen
      • Ketoprofen
      • Naproxen
      • OTC Triptans
  • Topical Analgesics/Anaesthetic


Analgesics cover systemic and topical pain relievers. Products which include a pain-relief ingredient in addition to another core function are excluded (e.g. a sore throat remedy which includes paracetamol is excluded from the analgesics and instead is included in pharyngeal remedies).

See All of Our Definitions

Why buy this report?

  • Gain competitive intelligence about market leaders
  • Track key industry trends, opportunities and threats
  • Inform your marketing, brand, strategy and market development, sales and supply functions

This report originates from Passport, our Analgesics research and analysis database.


If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extraction Free!